Non-canonical ubiquitin-based signals for proteasomal degradation

Regulated cellular proteolysis is mediated largely by the ubiquitin–proteasome system (UPS). It is a highly specific process that is time- (e.g. cell cycle), compartment- (e.g. nucleus or endoplasmic reticulum) and substrate quality- (e.g. denatured or misfolded proteins) dependent, and allows fast adaptation to changing conditions. Degradation by the UPS is carried out through two successive steps: the substrate is covalently tagged with ubiquitin and subsequently degraded by the 26S proteasome. The accepted ‘canonical’ signal for proteasomal recognition is a polyubiquitin chain that is anchored to a lysine residue in the target substrate, and is assembled through isopeptide bonds involving lysine 48 of ubiquitin. However, several ‘non-canonical’ ubiquitin-based signals for proteasomal targeting have also been identified. These include chains anchored to residues other than internal lysine in the substrates, chains assembled through linking residues other than lysine 48 in ubiquitin, and mixed chains made of both ubiquitin and a ubiquitin-like protein. Furthermore, some proteins can be degraded following modification by a single ubiquitin (monoubiquitylation) or multiple single ubiquitins (multiple monoubiquitylation). Finally, some proteins can be proteasomally degraded without prior ubiquitylation (the process is also often referred to as ubiquitination). In this Commentary, we describe these recent findings and discuss the possible physiological roles of these diverse signals. Furthermore, we discuss the possible impact of this signal diversity on drug development.

[1]  Mårten Fryknäs,et al.  Inhibition of proteasome deubiquitinating activity as a new cancer therapy , 2011, Nature Medicine.

[2]  A. Ciechanover,et al.  The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation , 2011, Nature Reviews Molecular Cell Biology.

[3]  Anindya Dutta,et al.  Selective Ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G Ubiquitin-Conjugating Enzymes via the CRL4Cdt2 Ubiquitin Ligase Complex , 2011, Molecular and Cellular Biology.

[4]  Anthony W. Purcell,et al.  Linear ubiquitination prevents inflammation and regulates immune signalling , 2011, Nature.

[5]  B. Maček,et al.  SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis , 2011, Nature.

[6]  Y. Saeki,et al.  SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex , 2011, Nature.

[7]  S. Gygi,et al.  A Perturbed Ubiquitin Landscape Distinguishes Between Ubiquitin in Trafficking and in Proteolysis* , 2011, Molecular & Cellular Proteomics.

[8]  Ceri M. Wiggins,et al.  BIMEL, an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation , 2011, Journal of Cell Science.

[9]  Junmin Peng,et al.  Diverse polyubiquitin chains accumulate following 26S proteasomal dysfunction in mammalian neurones , 2011, Neuroscience Letters.

[10]  Xianghui Yu,et al.  N-Terminal Hemagglutinin Tag Renders Lysine-Deficient APOBEC3G Resistant to HIV-1 Vif-Induced Degradation by Reduced Polyubiquitination , 2011, Journal of Virology.

[11]  John Rush,et al.  Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[12]  T. Rando,et al.  Taf1 regulates Pax3 protein by monoubiquitination in skeletal muscle progenitors. , 2010, Molecular cell.

[13]  A. Goldberg,et al.  ATP-dependent steps in the binding of ubiquitin conjugates to the 26S proteasome that commit to degradation. , 2010, Molecular cell.

[14]  A. Philpott,et al.  Non-canonical ubiquitylation of the proneural protein Ngn2 occurs in both Xenopus embryos and mammalian cells. , 2010, Biochemical and biophysical research communications.

[15]  J. Chin,et al.  Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. , 2010, Nature chemical biology.

[16]  A. Schwartz,et al.  Ubiquitin Proteasome-dependent Degradation of the Transcriptional Coactivator PGC-1α via the N-terminal Pathway* , 2010, The Journal of Biological Chemistry.

[17]  Christine Yu,et al.  K11-linked polyubiquitination in cell cycle control revealed by a K11 linkage-specific antibody. , 2010, Molecular cell.

[18]  David Komander,et al.  Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne , 2010, Nature Structural &Molecular Biology.

[19]  J. Larraín,et al.  Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan4 , 2010, The Journal of Biological Chemistry.

[20]  Min Jae Lee,et al.  Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14 , 2010, Nature.

[21]  T. Hunter,et al.  Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1 and p57Kip2 CDK inhibitors , 2010, Cell cycle.

[22]  M. Rapé,et al.  Regulated degradation of spindle assembly factors by the anaphase-promoting complex. , 2010, Molecular cell.

[23]  Daniel P. Stewart,et al.  Ubiquitin-Independent Degradation of Antiapoptotic MCL-1 , 2010, Molecular and Cellular Biology.

[24]  H. Ulrich,et al.  Distinct consequences of posttranslational modification by linear versus K63-linked polyubiquitin chains , 2010, Proceedings of the National Academy of Sciences.

[25]  B. André,et al.  The ubiquitin code of yeast permease trafficking. , 2010, Trends in cell biology.

[26]  G. Du,et al.  Dependence of Phospholipase D1 Multi-monoubiquitination on Its Enzymatic Activity and Palmitoylation* , 2010, The Journal of Biological Chemistry.

[27]  D. Fushman,et al.  Exploring the linkage dependence of polyubiquitin conformations using molecular modeling. , 2010, Journal of molecular biology.

[28]  M. Kirschner,et al.  UBE2S drives elongation of K11-linked ubiquitin chains by the Anaphase-Promoting Complex , 2010, Proceedings of the National Academy of Sciences.

[29]  W. Weis,et al.  Agonist-selective Dynamic Compartmentalization of Human Mu Opioid Receptor as Revealed by Resolutive FRAP Analysis* , 2009, The Journal of Biological Chemistry.

[30]  Gary H Karpen,et al.  Identification of a physiological E2 module for the human anaphase-promoting complex , 2009, Proceedings of the National Academy of Sciences.

[31]  Soichi Wakatsuki,et al.  Ubiquitin-binding domains — from structures to functions , 2009, Nature Reviews Molecular Cell Biology.

[32]  Paul Russell,et al.  UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit , 2009, Nature Cell Biology.

[33]  A. Ciechanover,et al.  Ubiquitin degradation with its substrate, or as a monomer in a ubiquitination-independent mode, provides clues to proteasome regulation , 2009, Proceedings of the National Academy of Sciences.

[34]  F. Blasi,et al.  Proteomics Analysis of Nucleolar SUMO-1 Target Proteins upon Proteasome Inhibition* , 2009, Molecular & Cellular Proteomics.

[35]  S. Gygi,et al.  S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains , 2009, The EMBO journal.

[36]  Vivian F Su,et al.  Ubiquitin-like and ubiquitin-associated domain proteins: significance in proteasomal degradation , 2009, Cellular and Molecular Life Sciences.

[37]  Yuanyan Wei,et al.  HSP70 protects BCL2L12 and BCL2L12A from N‐terminal ubiquitination‐mediated proteasomal degradation , 2009, FEBS letters.

[38]  John Rush,et al.  Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation , 2009, Cell.

[39]  A. Philpott,et al.  Ubiquitylation on Canonical and Non-canonical Sites Targets the Transcription Factor Neurogenin for Ubiquitin-mediated Proteolysis* , 2009, The Journal of Biological Chemistry.

[40]  A. Ciechanover,et al.  Modification by single ubiquitin moieties rather than polyubiquitination is sufficient for proteasomal processing of the p105 NF-kappaB precursor. , 2009, Molecular cell.

[41]  H. Yokosawa,et al.  Lysine 63‐linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome , 2009, The EMBO journal.

[42]  Zhijian J. Chen,et al.  Nonproteolytic functions of ubiquitin in cell signaling. , 2009, Molecular cell.

[43]  K. Ishii,et al.  Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28γ-Dependent Mechanism , 2008, Journal of Virology.

[44]  A. Matouschek,et al.  Substrate selection by the proteasome during degradation of protein complexes , 2008, Nature chemical biology.

[45]  C. Prives,et al.  Lysine-Independent Turnover of Cyclin G1 Can Be Stabilized by B′α Subunits of Protein Phosphatase 2A , 2008, Molecular and Cellular Biology.

[46]  J. Ou,et al.  Ubiquitin-Independent Degradation of Hepatitis C Virus F Protein , 2008, Journal of Virology.

[47]  V. Schreiber,et al.  The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects' Review Series , 2008, EMBO reports.

[48]  Anindya Dutta,et al.  PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. , 2008, Genes & development.

[49]  Youngjo Kim,et al.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. , 2008, Genes & development.

[50]  A. Goldberg,et al.  Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins , 2008, The Journal of cell biology.

[51]  A. Sharrocks Faculty Opinions recommendation of Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. , 2008 .

[52]  Ivan Dikic,et al.  Atypical ubiquitin chains: new molecular signals , 2008, EMBO reports.

[53]  M. Tatham,et al.  RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation , 2008, Nature Cell Biology.

[54]  M. Lei,et al.  Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway , 2008, Nature Cell Biology.

[55]  M. Rapé,et al.  Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex , 2008, Cell.

[56]  Anna M. Keller,et al.  Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment , 2007, The Journal of cell biology.

[57]  S. K. Lim,et al.  Antizyme1 mediates AURKAIP1-dependent degradation of Aurora-A , 2007, Oncogene.

[58]  M. Pagano,et al.  APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. , 2007, Molecular cell.

[59]  T. Rando,et al.  Regulation of Pax3 by Proteasomal Degradation of Monoubiquitinated Protein in Skeletal Muscle Progenitors , 2007, Cell.

[60]  J. Dewille,et al.  Proteasome-mediated CCAAT/enhancer-binding protein δ (C/EBPδ) degradation is ubiquitin-independent , 2007 .

[61]  B. O’Malley,et al.  Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. , 2007, Molecular cell.

[62]  James M. Roberts,et al.  Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.

[63]  Steven P Gygi,et al.  Certain Pairs of Ubiquitin-conjugating Enzymes (E2s) and Ubiquitin-Protein Ligases (E3s) Synthesize Nondegradable Forked Ubiquitin Chains Containing All Possible Isopeptide Linkages* , 2007, Journal of Biological Chemistry.

[64]  E. Wiertz,et al.  Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3 , 2007, The Journal of cell biology.

[65]  G. Gopalan,et al.  Aurora-A kinase interacting protein 1 (AURKAIP1) promotes Aurora-A degradation through an alternative ubiquitin-independent pathway. , 2007, The Biochemical journal.

[66]  Aaron Ciechanover,et al.  The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. , 2006, Molecular cell.

[67]  Keiji Tanaka,et al.  A ubiquitin ligase complex assembles linear polyubiquitin chains , 2006, The EMBO journal.

[68]  S. Gygi,et al.  Quantitative analysis of in vitro ubiquitinated cyclin B1 reveals complex chain topology , 2006, Nature Cell Biology.

[69]  Keith D Wilkinson,et al.  The discovery of ubiquitin-dependent proteolysis , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Xuedong Liu,et al.  Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection. , 2005, Biochemistry.

[71]  Beatriz Alvarez-Castelao,et al.  Mechanism of direct degradation of IκBα by 20S proteasome , 2005 .

[72]  K. Cadwell,et al.  Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase , 2005, Science.

[73]  Y. Shaul,et al.  20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. , 2005, Molecular cell.

[74]  Y. Shaul,et al.  A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. , 2005, Genes & development.

[75]  James M. Roberts,et al.  N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). , 2004, Molecular cell.

[76]  Ruchi M. Newman,et al.  Antizyme Targets Cyclin D1 for Degradation , 2004, Journal of Biological Chemistry.

[77]  A. Ciechanover,et al.  The Tumor Suppressor Protein p16INK4a and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System , 2004, Journal of Biological Chemistry.

[78]  Mei-Ling Kuo,et al.  N-terminal polyubiquitination and degradation of the Arf tumor suppressor. , 2004, Genes & development.

[79]  P. Thibault,et al.  N-Terminal Ubiquitination of Extracellular Signal-Regulated Kinase 3 and p21 Directs Their Degradation by the Proteasome , 2004, Molecular and Cellular Biology.

[80]  Xinbin Chen,et al.  MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53* , 2004, Journal of Biological Chemistry.

[81]  A. Ciechanover,et al.  Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination. , 2004, Biochemical and biophysical research communications.

[82]  M. Dai,et al.  MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation , 2003, The EMBO journal.

[83]  M. Pagano,et al.  Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation , 2003, Cell.

[84]  Steven P Gygi,et al.  A proteomics approach to understanding protein ubiquitination , 2003, Nature Biotechnology.

[85]  M. Pagano,et al.  Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase* , 2003, Journal of Biological Chemistry.

[86]  M. Glickman,et al.  Proteasome Disassembly and Downregulation Is Correlated with Viability during Stationary Phase , 2003, Current Biology.

[87]  K. Davies,et al.  Selective degradation of oxidatively modified protein substrates by the proteasome. , 2003, Biochemical and biophysical research communications.

[88]  C. Pickart,et al.  In Vitro Assembly and Recognition of Lys-63 Polyubiquitin Chains* , 2001, The Journal of Biological Chemistry.

[89]  A. Ciechanover,et al.  Degradation of the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) by the Ubiquitin-Proteasome Pathway , 2000, The Journal of Biological Chemistry.

[90]  B. Clurman,et al.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. , 2000, Molecular cell.

[91]  Martin Rechsteiner,et al.  Recognition of the polyubiquitin proteolytic signal , 2000, The EMBO journal.

[92]  S. Jentsch,et al.  A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly , 1999, Cell.

[93]  A. Ciechanover,et al.  A novel site for ubiquitination: the N‐terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein , 1998, The EMBO journal.

[94]  A. Ciechanover,et al.  Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .

[95]  B. Friguet,et al.  The carboxy-terminus of IκBα determines susceptibility to degradation by the catalytic core of the proteasome , 1997, Oncogene.

[96]  A. Haas,et al.  Novel Multiubiquitin Chain Linkages Catalyzed by the Conjugating Enzymes E2EPF and RAD6 Are Recognized by 26 S Proteasome Subunit 5 (*) , 1996, The Journal of Biological Chemistry.

[97]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[98]  S. Matsufuji,et al.  Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.

[99]  A. Ciechanover,et al.  Degradation of ornithine decarboxylase in reticulocyte lysate is ATP-dependent but ubiquitin-independent. , 1989, The Journal of biological chemistry.

[100]  D. Ecker,et al.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. , 1989, Science.

[101]  A. Goldberg,et al.  Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. , 1987, The Journal of biological chemistry.

[102]  A. Goldberg,et al.  Red blood cells contain a pathway for the degradation of oxidant-damaged hemoglobin that does not require ATP or ubiquitin. , 1986, The Journal of biological chemistry.

[103]  H. Ulrich,et al.  The SUMO system: an overview. , 2009, Methods in molecular biology.

[104]  J. Dewille,et al.  Proteasome-mediated CCAAT/enhancer-binding protein delta (C/EBPdelta) degradation is ubiquitin-independent. , 2007, The Biochemical journal.

[105]  Beatriz Alvarez-Castelao,et al.  Mechanism of direct degradation of IkappaBalpha by 20S proteasome. , 2005, FEBS letters.

[106]  A. Ciechanover,et al.  The Tumor Suppressor Protein p 16 INK 4 a and the Human Papillomavirus Oncoprotein-58 E 7 Are Naturally Occurring Lysine-less Proteins , 2004 .

[107]  D. Thomas,et al.  The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome. , 1997, Oncogene.

[108]  A. Ciechanover,et al.  Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. , 1997, The EMBO journal.